VERNON W ANTHONY 4

What Happened

• Vernon W. Anthony, a director of NovoCure Ltd (NVCR), sold 2,945 shares on 2026-06-02 for a weighted average price of $15.77, generating approximately $46,445 in proceeds. The filing reports the sale as an open-market/private sale (Code S) and is a sell-to-cover tied to RSU vesting rather than a discretionary trade.

Key Details

• Transaction date: 2026-06-02; Form 4 filed: 2026-06-03 (timely).
• Price: weighted average $15.77; execution range $15.65–$15.88 (multiple trades) — see footnote F2.
• Shares sold: 2,945; proceeds ≈ $46,445.
• Shares owned after the transaction: not disclosed in this Form 4.
• Footnote F1: Sale was required to satisfy tax withholding obligations on vested Restricted Stock Units (i.e., a mandated "sell-to-cover"), not a voluntary sale.
• Transaction code: S = Sale; filing shows no indication of a 10b5-1 plan or late filing.

Context

• Sell-to-cover transactions are routine when RSUs vest and typically reflect tax-withholding mechanics rather than an insider signaling a view on the stock. This transaction does not, by itself, indicate insider confidence or concern.